InvestorsHub Logo
Followers 15
Posts 697
Boards Moderated 0
Alias Born 10/03/2017

Re: None

Sunday, 04/28/2024 11:14:34 PM

Sunday, April 28, 2024 11:14:34 PM

Post# of 424250
Effects of icosapent ethyl according to baseline residual risk in patients with atherosclerotic cardiovascular disease: results from REDUCE-IT

Pascal M Burger, MD, Deepak L Bhatt, MD, MPH, MBA, Jannick A N Dorresteijn, MD, PhD, Stefan Koudstaal, MD, PhD, Arend Mosterd, MD, PhD, Fabrice M A C Martens, MD, PhD, P Gabriel Steg, MD, Frank L J Visseren, MD, PhD for the REDUCE-IT Investigators

European Heart Journal - Cardiovascular Pharmacotherapy, pvae030, https://doi.org/10.1093/ehjcvp/pvae030

Published: 27 April 2024



https://academic.oup.com/ehjcvp/advance-article/doi/10.1093/ehjcvp/pvae030/7659360
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News